Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Nov 30, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	3,004	$180.08	11,400
Nov 30, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	400	$181.59	11,000
Nov 29, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,097	$182.20	17,737
Nov 29, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	3,333	$182.20	14,404
Nov 30, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	200	$182.39	10,800
Dec 10, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	1,257	$182.68	16,743
Dec 10, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3	2,875	$182.68	13,868
Nov 30, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	200	$183.77	10,600
Nov 30, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	100	$184.00	10,500
Dec 11, 2012	Aberman Michael S VP Strategy and Investor Relat	VP Strategy and Investor Relat	Form 4	Open market or private sale of non-derivative or derivative security	1,268	$184.85	12,600

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media